01 10Aloxi
Main Therapeutic Indication : Anti-Emetic
Currency : USD
2020 Revenue in Millions : 150
2019 Revenue in Millions : 147
Growth (%) : 2
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2021 Revenue in Millions : 123
2020 Revenue in Millions : 144
Growth (%) : -8
Main Therapeutic Indication : Gastrointestinal Diseases
Currency : USD
2022 Revenue in Millions : 27
2021 Revenue in Millions : 123
Growth (%) : -78
Main Therapeutic Indication : Gastrointestinal Diseases
Currency : USD
2023 Revenue in Millions : 14
2022 Revenue in Millions : 27
Growth (%) : -42
Main Therapeutic Indication : Anti-emetic
Currency : USD
2017 Revenue in Millions : 430
2016 Revenue in Millions : 465
Growth (%) : -7
Main Therapeutic Indication : Anti-Emetic
Currency : USD
2018 Revenue in Millions : 83
2017 Revenue in Millions : 403
Growth (%) : -79%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 126
2015 Revenue in Millions : 117
Growth (%) : 8
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 139
2016 Revenue in Millions : 134
Growth (%) : 4
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 132
2017 Revenue in Millions : 131
Growth (%) : 1%
Main Therapeutic Indication : Anti-Emetic
Currency : USD
2019 Revenue in Millions : 144
2018 Revenue in Millions : 137
Growth (%) : 5
LOOKING FOR A SUPPLIER?